Information Provided By: 
Fly News Breaks for March 4, 2019
PRAH
Mar 4, 2019 | 05:41 EDT
Mizuho analyst Ann Hynes raised her price target for PRA Health Sciences to $106 citing the company's "strong" cash flow and keeps a Neutral rating on the name. The slowing down in Q4 was deemed as a transition period and the business is expected to be back on the track of high-single-digit to low-double-digit organic growth going through 2019, Hynes tells investors in a post-earnings research note. She keeps a Neutral rating on PRA Health.
News For PRAH From the Last 2 Days
There are no results for your query PRAH
